Med Device: An Improved Stylet for Endotracheal Tube Placement

Antibodies: Use of Antibodies to MARCO for Enhanced Dendritic Cell Vaccine Efficacy

Vaccine: Vaccines Using Synthetic Peptide-Poly IC Complexes that Elicit T-cell Responses Comparable to Live Vaccination

Cancer Vaccine: Full-Length Variant Survivin Vaccine Potentiates Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

TLR9: Targeting Chimeric Antigen Receptor-Expressing T cell (CAR-T) for MDS and AML Immunotherapy

AaPC: Artificial Antigen-Presenting Cells for Expanding TILs and MILs in Cancer Immunotherapy

IL-13Rα2: Targeting Chimeric Antigen Receptor Expressing T cell (CAR-T) for Melanoma Immunotherapy

CD3-CD28: Bispecific Antibody for the Generation of CAR-T cells for Cancer Immunotherapy

TILs: Simple and Rapid Method for Culture of TILs from Melanoma Tumor Fragments or Core Needle Biopsies of Solid Tumors

AaPC: Artificial Antigen-Presenting Cells with Heparin-Binding Domain and Protein L for Producing CAR-T Cells

Glioma Stem Cell Targeting CAR-T Cell Constructs with Phage Display Derived Peptide Oligomers

Brain Mets: Lung Cancer Brain Metastases Targeting CAR-T Cell Constructs with Phage Display Derived Peptide Oligomers

Antibodies: Fully Human anti-LAG3 Antibodies

Research Tool: Improved Electroporation Buffer for Enhanced Efficiency and Viability

Software: Improved Detection of Lung Function and Management of Lung Cancer Radio Therapy

Software: Method for Improving the Accuracy of Charged Particle Beam (High Energy Proton or Carbon Ion Beam) Radiotherapy

Software: An Automated Mammographic Density Measure for Improved Breast Cancer Screening

Software: BMT Research Analysis Information Network (BRAIN)

Software: Decision Support Tool for Oncology Treatment using Mathematical Simulations

Software: Real-time Visualization Software Enables Surgeons to “see-through” the patient and remove tumors more effectively

Software: A Quantitative Framework to Identify Radiation Targets for Cancer Treatment that Synergize with Immunotherapy

Software: Negative Information Storage Model for Genomic Dat

Aurora: Novel Small Molecule Aurora A Kinase Inhibitor as a Cancer Therapeutic

pH: Systemic Buffers as Inhibitors of Cancer Metastasis

Mcl-1: Asymmetrical Marinopyrroles as Anti-Cancer Agents

LPAAT: Lysophosphatidic Acid Acyltransferase-Beta Inhibitors to Treat Pancreatic Cancer

FT/GGT: Novel Dual Inhibitor of Farnesyltransferase and Geranylgeranyltransferase-1 as an Anti-Cancer Agentbitor

Proteasome: Non-covalent and Reversible Proteasome Inhibitors with an Oxadiazole-isopropylamide Core

HDAC6: Novel Small Molecule Histone Deacetylase 6 Inhibitor with a Substituted Aryl Urea Cap Group

Mcl-1/Bcl-xL: Cyclic, Symmetrical and Asymmetrical Marinopyrroles as Anti-Cancer Agents

IRE-1: Novel Small Molecule Inhibitors of IRE-1 for the Treatment of B-cell Cancer

STAT3: Novel Small Molecule STAT3 Inhibitor for Cancer Treatment

Novel Symmetrical Marinopyrrole Derivative as a Therapeutic against Resistant Bacterial Strains

BRD4 JAK2: Novel BRD4/JAK2 Dual Inhibitors as Cancer Therapeutics

WEE1: Small Molecule WEE1 Inhibitor (WEIN-159) that Inhibits WEE1 Phosphorylation of H2B but Not Cdc2 to Treat Can

Ras: Small Molecules that Inhibit Mutant KRAS

Ras/Raf: Stapled Peptides as Inhibitors of Mutant KRAS

Aurora/JAK2: Dual JAK2 and Aurora A Kinase Inhibitor for GVHD Prophylaxis

β-catenin/BCL-9: Small Molecules that Inhibit the β-catenin/BCL9 Interaction

XBP-1: XBP-1 Inhibitor B-I09 for the Treatment of Acute GVHD and Solid Organ Rejection

Antibody Diagnostic: Monitoring Multiple Myeloma Progression and Recurrence

Genetic Signature: Immune-related Gene Signature to Influence Treatment Decisions and Predict Immunotherapy Outcomes in Cancer

Molecular Imaging Probe: Breast Cancer-Targeted Probe Set for Improved Detection of Lymph Node Metastases

Molecular Imaging Probe: Fluorescent and MRI Targeted Probes for the Melanocortin Receptor 1 on Melanomas, and Micelle Complexes for Drug Delivery

Protein Diagnostic: New Receptor Tyrosine Kinase Assay for Patient Treatment Selection Based on Protein-Protein Bindi

Imaging: Digital Pathology Tool to Grade Breast Cancer Histological Images

Molecular Imaging Probe: Surrogate Markers for Colon Adenoma and Adenocarcinoma

Molecular Imaging Probe: Synthetic Fluorescent Probe for Improved Detection and Tumor Removal in Pancreatic Cancer Patients

Gene Signature for Immunotherapy Response Prediction in Cancer Based on Nuclear Factor-kappa B

Protein Diagnostic: Mass Spectrometry Diagnostic for BRAF and Heat Shock Proteins

Genetic Signature: Gene Expression Signature to Determine the Benefit of Adjuvant Chemotherapy in Early Stage Non-Small Cell Lung Cancer

Molecular Imaging Probe: A Novel 18F Scaffold for Preparing Targeted PET Imaging Probess

Protein Diagnostic: Phosphorylated STAT3 Protein as a Novel Biomarker of Graft Versus Host Disease

Multiplex Diagnostic: Detection of Minimal Residual Disease in Multiple Myeloma Using RNA Sequencing and Mass Spectrometry

Genetic Signature: Gene Signature Predicts Recurrence and Benefit From Adjuvant Chemotherapy in Colorectal Cancer

Imaging: Decision Support Tool for Oncology Treatment that Analyzes Radiological Images

Molecular Imaging: Texture Feature Analysis of Low-Dose CT Images for Pulmonary Nodule Diagnosis

Molecular Imaging: Novel Imaging Software Diagnostic to Determine Survival in Glioblastoma Multiforme

Molecular Imaging: PET Probes of Radiofluorinated Carboximidamides for IDO-Targeted Imaging

miRNA Diagnostic: Blood Based microRNA Assay to Detect Malignant Intraductal Papillary Mucinous Neoplasms (IPMNs)

Protein Biomarker: Expression of WEE1 and PAXIP1 Can Select Patients who Respond to WEE1 Inhibitor Therapys

Genetic Signature: Microarray-based Gene Expression Profiling to Predict Tumor Sensitivity to Radiotherapy

Molecular Imaging: Monoacylated TLR2 Ligand Fluorescent Probe for Detecti

Diagnostic: Intracellular S100A9 Alone or NLRP3 Inflammasome Activation as MDS Biomarkers

Diagnostic: S100A9 Serum Concentration Levels Predict Lenalidomide Response Duration

Molecular Imaging Probe: In vivo Positron Emission Tomography-Based Perfusion/Blood Pool Imaging Using Labeled Erythrocytes

Protein Biomarker: Diagnostic for Progression of MDS to AML Using PD-1 or PD-L1 Expression

Genetic Signature: Gene Signature to Distinguish Lung Squamous Cell Carcinoma from Metastatic Head & Neck Squamous Cell Carcinoma

Protein Biomarker: Method for Measuring MRE11 in Muscle –Invasive Bladder Cancer to Predict Chemoradiation Response Using AQUA

Protein Biomarker: Diagnostic to Determine which Low-Risk MDS Patients to Treat with Lenalidomide to Restore Sensitivity to Erythropoietin

Molecular Imaging Probe: Novel IDO1-Targeting Cancer Diagnostic PET Imaging Agent

miRNA Diagnostic: MicroRNA Signature to Predict Progression of Barrett’s Esophagus to Esophageal Dysplasia or Adenocarcinoma

Genetic Biomarker: PTEN Mutation as a Novel Biomarker of Response to GGTI-2418 Treatment in Cancer

Genetic Signature: Gene Signature to Distinguish between Metastatic Urothelial Carcinoma and Squamous Cell Carcinoma (Primary Lung and Metastatic Head & Neck)

Med Device: Handheld Radioisotope Identification Device (RIID)

Med Device: Muscle Stapler

Med Device: Pump-assisted High Flow Rate Isolated Limb Infusion for Regional Cancer Treatment

Med Device: Minimally Invasive Spinal Fusion Using a Transdiscal Screw System

Med Device: Improved Endotracheal Tube to Prevent Intubation-Related Complications Related to Airway Edema (Swelling)

Med Device: Improved Arterial Catheter to Prevent Blood Hospital Acquired Infections

Med Device: Improved Enteral Feeding Tube and Retention Disc to Reduce Dislodgement, Infection and Complications

Med Device: Novel Orogastric Tube Guide for Accurate Placement While Reducing Cross Contamination

Med Device: Expandable Intervertebral Cage for Spinal Fusion

Med Device: An Improved Pigtail Drainage Catheter for Percutaneous Fluid Aspiration

Med Device: The STAT-Clip Prevents Blood Leakage upon Intra-Venous Catheter Insertion

Olfactory Receptor Targeting Chimeric Antigen Receptor Expressing T cell (CAR-T) for Solid Tumors

CMG Helicase: Novel Replicative CMG Helicase Inhibitors (CMGi) to Treat Solid Tumors